Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Neonatology

  Free Subscription


Articles published in Thorax

Retrieve available abstracts of 86 articles:
HTML format
Text format



Single Articles


    June 2015
  1. SUBBARAO P, Anand SS, Becker AB, Befus AD, et al
    The Canadian Healthy Infant Longitudinal Development (CHILD) Study: examining developmental origins of allergy and asthma.
    Thorax. 2015 Jun 11. pii: thoraxjnl-2015-207246.
    PubMed     Text format     Abstract available


    May 2015
  2. QUITTNER AL, Barker D, Goldbeck L, Duff A, et al
    Letter to the editor: authors' response.
    Thorax. 2015;70:490-1.
    PubMed     Text format    


  3. BRYON M, Webb AK
    Response to: 'on the TIDES study', by Quittner et al.
    Thorax. 2015;70:490.
    PubMed     Text format    


  4. PECKHAM D, Whitaker P, White H
    Research in progress-electronic patient records: a new era.
    Thorax. 2015;70:473-5.
    PubMed     Text format     Abstract available


    April 2015
  5. BLAIS L, Kettani FZ, Forget A, Beauchesne MF, et al
    Asthma exacerbations during the first trimester of pregnancy and congenital malformations: revisiting the association in a large representative cohort.
    Thorax. 2015 Apr 17. pii: thoraxjnl-2014-206634.
    PubMed     Text format     Abstract available


  6. LEE DC, Walker SA, Byrne AJ, Gregory LG, et al
    Perinatal paracetamol exposure in mice does not affect the development of allergic airways disease in early life.
    Thorax. 2015 Apr 3. pii: thoraxjnl-2014-205280.
    PubMed     Text format     Abstract available


    March 2015
  7. BOLTON CE, Bush A, Hurst JR, Kotecha S, et al
    Lung consequences in adults born prematurely.
    Thorax. 2015 Mar 30. pii: thoraxjnl-2014-206590.
    PubMed     Text format     Abstract available


  8. CHALMERS JD, Elborn JS
    Reclaiming the name 'bronchiectasis'.
    Thorax. 2015 Mar 19. pii: thoraxjnl-2015-206956.
    PubMed     Text format    


  9. TAYLOR-ROBINSON DC, Schechter MS, Smyth RL
    Comparing cystic fibrosis outcomes across the pond.
    Thorax. 2015;70:203-4.
    PubMed     Text format    


  10. KOSMIDIS C, Denning DW
    The clinical spectrum of pulmonary aspergillosis.
    Thorax. 2015;70:270-7.
    PubMed     Text format     Abstract available


  11. GOSS CH, MacNeill SJ, Quinton HB, Marshall BC, et al
    Children and young adults with CF in the USA have better lung function compared with the UK.
    Thorax. 2015;70:229-36.
    PubMed     Text format     Abstract available


    January 2015
  12. GALAMBOS C, Sims-Lucas S, Ali N, Gien J, et al
    Intrapulmonary vascular shunt pathways in alveolar capillary dysplasia with misalignment of pulmonary veins.
    Thorax. 2015;70:84-5.
    PubMed     Text format     Abstract available


    December 2014
  13. EVERARD ML, Hind D, Ugonna K, Freeman J, et al
    SABRE: a multicentre randomised control trial of nebulised hypertonic saline in infants hospitalised with acute bronchiolitis.
    Thorax. 2014;69:1105-12.
    PubMed     Text format     Abstract available


  14. WEBB AK, Bryon M
    The International Depression Epidemiological Study (TIDES): unfinished business?
    Thorax. 2014;69:1067-8.
    PubMed     Text format    


  15. QUITTNER AL, Goldbeck L, Abbott J, Duff A, et al
    Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries.
    Thorax. 2014;69:1090-7.
    PubMed     Text format     Abstract available


    October 2014
  16. GILL DR, Hyde SC
    Delivery of genes into the CF airway.
    Thorax. 2014;69:962-4.
    PubMed     Text format     Abstract available


    September 2014
  17. BILTON D, Tino G, Barker AF, Chambers DC, et al
    Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
    Thorax. 2014 Sep 21. pii: thoraxjnl-2014-205587.
    PubMed     Text format     Abstract available


    August 2014
  18. MERKUS PJ
    Setting the stage for CFTR modulator studies in infants.
    Thorax. 2014 Aug 6. pii: thoraxjnl-2013-204248.
    PubMed     Text format    


  19. JONES AM
    Airborne dissemination of transmissible bacterial species in cystic fibrosis.
    Thorax. 2014;69:690-1.
    PubMed     Text format    


  20. KNIBBS LD, Johnson GR, Kidd TJ, Cheney J, et al
    Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis.
    Thorax. 2014;69:740-5.
    PubMed     Text format     Abstract available


    June 2014
  21. BARRY PJ, Jones AM, Webb AK, Horsley AR, et al
    Sweat chloride is not a useful marker of clinical response to Ivacaftor.
    Thorax. 2014;69:586-7.
    PubMed     Text format     Abstract available


    March 2014
  22. SOSNAY PR, Cutting GR
    Interpretation of genetic variants.
    Thorax. 2014;69:295-7.
    PubMed     Text format     Abstract available


  23. OOI CY, Dupuis A, Ellis L, Jarvi K, et al
    Does extensive genotyping and nasal potential difference testing clarify the diagnosis of cystic fibrosis among patients with single-organ manifestations of cystic fibrosis?
    Thorax. 2014;69:254-60.
    PubMed     Text format     Abstract available


  24. FLIGHT WG, Bright-Thomas RJ, Tilston P, Mutton KJ, et al
    Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis.
    Thorax. 2014;69:247-53.
    PubMed     Text format     Abstract available


    February 2014
  25. HORSLEY A
    Author's response: heterogeneity of change in LCI in patients with cystic fibrosis following antibiotic treatment.
    Thorax. 2014;69:184.
    PubMed     Text format    


  26. YAMMINE S, Bigler A, Casaulta C, Singer F, et al
    Reasons for heterogeneous change in LCI in children with cystic fibrosis after antibiotic treatment.
    Thorax. 2014;69:183.
    PubMed     Text format    


    January 2014
  27. VERMEULEN F, Proesmans M, Boon M, Havermans T, et al
    Lung clearance index predicts pulmonary exacerbations in young patients with cystic fibrosis.
    Thorax. 2014;69:39-45.
    PubMed     Text format     Abstract available


    December 2013
  28. COHEN-CYMBERKNOH M, Kerem E, Ferkol T, Elizur A, et al
    Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications.
    Thorax. 2013;68:1157-62.
    PubMed     Text format     Abstract available


    November 2013
  29. ALTON EW, Boyd AC, Cheng SH, Cunningham S, et al
    A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis.
    Thorax. 2013;68:1075-7.
    PubMed     Text format     Abstract available


    October 2013
  30. THIA LP , Calder A, Stocks J, Bush A, et al
    Is chest CT useful in newborn screened infants with cystic fibrosis at 1 year of age?
    Thorax. 2013 Oct 16. doi: 10.1136/thoraxjnl-2013-204176.
    PubMed     Text format     Abstract available


  31. NICK JA, Sanders LA, Ickes B, Briones NJ, et al
    Blood mRNA biomarkers for detection of treatment response in acute pulmonary exacerbations of cystic fibrosis.
    Thorax. 2013;68:929-37.
    PubMed     Text format     Abstract available


    September 2013
  32. NGUYEN TT , Thia LP, Hoo AF, Bush A, et al
    Evolution of lung function during the first year of life in newborn screened cystic fibrosis infants.
    Thorax. 2013 Sep 26. doi: 10.1136/thoraxjnl-2013-204023.
    PubMed     Text format     Abstract available


  33. CLANCY JP, Dupont L, Konstan MW, Billings J, et al
    Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection.
    Thorax. 2013;68:818-25.
    PubMed     Text format     Abstract available


    August 2013
  34. BOLTON CE , Bush A
    Coming now to a chest clinic near you.
    Thorax. 2013;68:707-8.
    PubMed     Text format    


  35. MAIN E
    Airway clearance research in CF: the 'perfect storm' of strong preference and effortful participation in long-term, non-blinded studies.
    Thorax. 2013;68:701-2.
    PubMed     Text format    


  36. MCILWAINE MP , Alarie N, Davidson GF, Lands LC, et al
    Long-term multicentre randomised controlled study of high frequency chest wall oscillation versus positive expiratory pressure mask in cystic fibrosis.
    Thorax. 2013;68:746-51.
    PubMed     Text format     Abstract available


    July 2013
  37. KHANNA M , Shackleton C, Verheggen M, Sharp M, et al
    Evaluating hypoxia during air travel in healthy infants.
    Thorax. 2013 Jul 18. doi: 10.1136/thoraxjnl-2013-203905.
    PubMed     Text format     Abstract available


  38. NGUIPDOP-DJOMO P , Mangtani P, Pedrazzoli D, Rodrigues LC, et al
    Uptake of neonatal BCG vaccination in England: performance of the current policy recommendations.
    Thorax. 2013 Jul 13. doi: 10.1136/thoraxjnl-2013-203931.
    PubMed     Text format     Abstract available


  39. GUERRA S , Stern DA, Zhou M, Sherrill DL, et al
    Combined effects of parental and active smoking on early lung function deficits: a prospective study from birth to age 26 years.
    Thorax. 2013 Jul 11. doi: 10.1136/thoraxjnl-2013-203538.
    PubMed     Text format     Abstract available


  40. BAXTER CG , Rautemaa R, Jones AM, Webb AK, et al
    Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum.
    Thorax. 2013;68:652-7.
    PubMed     Text format     Abstract available


    June 2013
  41. SHARP C , Jackson J, Hands G
    Congenital thoracic malformation.
    Thorax. 2013 Jun 8. doi: 10.1136/thoraxjnl-2013-203708.
    PubMed     Text format    


  42. VOLLSAETER M , Roksund OD, Eide GE, Markestad T, et al
    Lung function after preterm birth: development from mid-childhood to adulthood.
    Thorax. 2013 Jun 7. doi: 10.1136/thoraxjnl-2012-202980.
    PubMed     Text format     Abstract available


  43. HORSLEY AR , Davies JC, Gray RD, Macleod KA, et al
    Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation.
    Thorax. 2013;68:532-9.
    PubMed     Text format     Abstract available


  44. YAMMINE S , Singer F, Abbas C, Roos M, et al
    Multiple-breath washout measurements can be significantly shortened in children.
    Thorax. 2013;68:586-7.
    PubMed     Text format     Abstract available


    May 2013
  45. KARAMANOU M , Androutsos G
    Antoine-Laurent de Lavoisier (1743-1794) and the birth of respiratory physiology.
    Thorax. 2013 May 30. doi: 10.1136/thoraxjnl-2013-203840.
    PubMed     Text format     Abstract available


  46. BAKER CD , Abman SH
    Umbilical cord stem cell therapy for bronchopulmonary dysplasia: ready for prime time?
    Thorax. 2013;68:402-4.
    PubMed     Text format    


  47. PIERRO M , Ionescu L, Montemurro T, Vadivel A, et al
    Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia.
    Thorax. 2013;68:475-84.
    PubMed     Text format     Abstract available


    April 2013
  48. KOTECHA SJ , Edwards MO, Watkins WJ, Henderson AJ, et al
    Effect of preterm birth on later FEV1: a systematic review and meta-analysis.
    Thorax. 2013 Apr 20. doi: 10.1136/thoraxjnl-2012-203079.
    PubMed     Text format     Abstract available


  49. COSSETTE B , Forget A, Beauchesne MF, Rey E, et al
    Impact of maternal use of asthma-controller therapy on perinatal outcomes.
    Thorax. 2013 Apr 13. doi: 10.1136/thoraxjnl-2012-203122.
    PubMed     Text format     Abstract available


  50. ROGERS GB , van der Gast CJ, Cuthbertson L, Thomson SK, et al
    Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.
    Thorax. 2013 Apr 6. doi: 10.1136/thoraxjnl-2012-203105.
    PubMed     Text format     Abstract available


  51. SOUTHERN KW , McCormack P, McNamara PS
    After a long wait, two arrive, one after the other!
    Thorax. 2013;68:311-2.
    PubMed     Text format    


  52. SCHUSTER A , Haliburn C, Doring G, Goldman MH, et al
    Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study.
    Thorax. 2013;68:344-50.
    PubMed     Text format     Abstract available


    March 2013
  53. TAYLOR-ROBINSON D , Whitehead M, Diderichsen F, Vebert Olesen H, et al
    Author's response: understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study.
    Thorax. 2013;68:294-5.
    PubMed     Text format    


  54. MILLER M
    FEV1 decline in cystic fibrosis.
    Thorax. 2013;68:294.
    PubMed     Text format    


    February 2013
  55. KOTECHA S , Davies PL, Clark HW, McGreal EP, et al
    Increased prevalence of low oligomeric state surfactant protein D with restricted lectin activity in bronchoalveolar lavage fluid from preterm infants.
    Thorax. 2013 Feb 6. doi: 10.1136/thoraxjnl-2012-202729.
    PubMed     Text format     Abstract available


  56. ABBOTT J , Hurley MA, Morton AM, Conway SP, et al
    Longitudinal association between lung function and health-related quality of life in cystic fibrosis.
    Thorax. 2013;68:149-54.
    PubMed     Text format     Abstract available


    January 2013
  57. BYRNES CA , Vidmar S, Cheney JL, Carlin JB, et al
    Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age.
    Thorax. 2013 Jan 23. doi: 10.1136/thoraxjnl-2012-202342.
    PubMed     Text format     Abstract available


  58. GHOSH RE , Cullinan P, Fishwick D, Hoyle J, et al
    Asthma and occupation in the 1958 birth cohort.
    Thorax. 2013 Jan 21. doi: 10.1136/thoraxjnl-2012-202151.
    PubMed     Text format     Abstract available


  59. PIKE KC , Inskip HM, Robinson SM, Cooper C, et al
    The relationship between maternal adiposity and infant weight gain, and childhood wheeze and atopy.
    Thorax. 2013 Jan 3. doi: 10.1136/thoraxjnl-2012-202556.
    PubMed     Text format     Abstract available


  60. MOTT LS , Park J, Murray CP, Gangell CL, et al
    Authors' response.
    Thorax. 2013;68:106.
    PubMed     Text format    


  61. HOCHHEGGER B , Irion KL, Marchiori E
    Chest MRI in patients with cystic fibrosis: a radiation-free method.
    Thorax. 2013;68:105-6.
    PubMed     Text format    


    December 2012
  62. BOLTON CE , Bush A, Hurst JR, Kotecha S, et al
    Are early life factors considered when managing respiratory disease? A British Thoracic Society survey of current practice.
    Thorax. 2012;67:1110.
    PubMed     Text format     Abstract available


    November 2012
  63. WHITTERS D , Stockley R
    Immunity and bacterial colonisation in bronchiectasis.
    Thorax. 2012;67:1006-13.
    PubMed     Text format     Abstract available


    October 2012
  64. ROWE SM , Borowitz DS, Burns JL, Clancy JP, et al
    Progress in cystic fibrosis and the CF Therapeutics Development Network.
    Thorax. 2012;67:882-90.
    PubMed     Text format     Abstract available


  65. CUNNINGHAM S
    What you don't know can hurt you; early asymptomatic lung disease in cystic fibrosis.
    Thorax. 2012;67:849-50.
    PubMed     Text format    


  66. LIPUMA J
    The new microbiology of cystic fibrosis: it takes a community.
    Thorax. 2012;67:851-2.
    PubMed     Text format    


  67. STRESSMANN FA , Rogers GB, van der Gast CJ, Marsh P, et al
    Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience.
    Thorax. 2012;67:867-73.
    PubMed     Text format     Abstract available


  68. FLIGHT WG , Bright-Thomas RJ, Butterfield S, Jones AM, et al
    A therapeutic conundrum: recurrent cystic-fibrosis-related haemoptysis complicated by acute pulmonary embolism.
    Thorax. 2012;67:931-2.
    PubMed     Text format     Abstract available


  69. TAYLOR-ROBINSON D , Whitehead M, Diderichsen F, Olesen HV, et al
    Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study.
    Thorax. 2012;67:860-6.
    PubMed     Text format     Abstract available


  70. TACCETTI G , Bianchini E, Cariani L, Buzzetti R, et al
    Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols.
    Thorax. 2012;67:853-9.
    PubMed     Text format     Abstract available


    August 2012
  71. SCOTT M , Roberts G, Kurukulaaratchy RJ, Matthews S, et al
    Multifaceted allergen avoidance during infancy reduces asthma during childhood with the effect persisting until age 18 years.
    Thorax. 2012.
    PubMed     Text format     Abstract available


  72. TRACHSEL D , Brutsche MH, Hug-Batschelet H, Hammer J, et al
    Progressive static pulmonary hyperinflation in survivors of severe bronchopulmonary dysplasia by mid-adulthood.
    Thorax. 2012;67:747-8.
    PubMed     Text format     Abstract available


    July 2012
  73. SIMMONDS NJ , Bush A
    Diagnosing cystic fibrosis: what are we sweating about?
    Thorax. 2012;67:571-3.
    PubMed     Text format    


  74. OOI CY , Dupuis A, Ellis L, Jarvi K, et al
    Comparing the American and European diagnostic guidelines for cystic fibrosis: same disease, different language?
    Thorax. 2012;67:618-24.
    PubMed     Text format     Abstract available


  75. FLIGHT WG , Jones AM
    Cystic fibrosis, primary ciliary dyskinesia and non-cystic fibrosis bronchiectasis: update 2008-11.
    Thorax. 2012;67:645-9.
    PubMed     Text format     Abstract available


    June 2012
  76. HOO AF , Thia LP, Nguyen TT, Bush A, et al
    Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening.
    Thorax. 2012.
    PubMed     Text format     Abstract available


  77. YOUNG C , Owens C
    'To CT or not to CT? That is the question': outcome surrogates for surveillance in childhood cystic fibrosis.
    Thorax. 2012;67:471-2.
    PubMed     Text format    


  78. VAREILLE M , Kieninger E, Alves MP, Kopf BS, et al
    Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells.
    Thorax. 2012;67:517-25.
    PubMed     Text format     Abstract available


  79. MOTT LS , Park J, Murray CP, Gangell CL, et al
    Progression of early structural lung disease in young children with cystic fibrosis assessed using CT.
    Thorax. 2012;67:509-16.
    PubMed     Text format     Abstract available


    May 2012
  80. BUSH A , Simmonds NJ
    Hot off the breath: 'I've a cost for'--the 64 million dollar question.
    Thorax. 2012;67:382-4.
    PubMed     Text format    


  81. WILLIAMS HD , Davies JC
    Basic science for the chest physician: Pseudomonas aeruginosa and the cystic fibrosis airway.
    Thorax. 2012;67:465-7.
    PubMed     Text format    


  82. HAN MK , Huang YJ, Lipuma JJ, Boushey HA, et al
    Significance of the microbiome in obstructive lung disease.
    Thorax. 2012;67:456-63.
    PubMed     Text format     Abstract available


    March 2012
  83. BAYES HK , Church AC, Fisher AJ
    Review of the British Thoracic Society Winter Meeting 2011, 7-9 December, London, U.K.
    Thorax. 2012;67:258-62.
    PubMed     Text format     Abstract available


  84. MONTUSCHI P , Paris D, Melck D, Lucidi V, et al
    NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis.
    Thorax. 2012;67:222-8.
    PubMed     Text format     Abstract available


    February 2012
  85. REGAMEY N , Tsartsali L, Hilliard TN, Fuchs O, et al
    Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis.
    Thorax. 2012;67:164-70.
    PubMed     Text format     Abstract available


  86. BURGEL PR , Martin C, Fajac I, Dusser DJ, et al
    Should bronchoscopy be advocated to study airway remodelling and inflammation in adults with cystic fibrosis?
    Thorax. 2012;67:177.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


All AMEDEO services are free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Amedeo is a Flying Publisher website.

   Design: